Annual Total Long Term Liabilities
$11.78 M
+$10.10 M+604.35%
December 31, 2023
Summary
- As of February 7, 2025, INVO annual total long term liabilities is $11.78 million, with the most recent change of +$10.10 million (+604.35%) on December 31, 2023.
- During the last 3 years, INVO annual total long term liabilities has risen by +$8.86 million (+303.82%).
Performance
INVO Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Long Term Liabilities
$8.39 M
-$292.05 K-3.36%
September 30, 2024
Summary
- As of February 7, 2025, INVO quarterly total long term liabilities is $8.39 million, with the most recent change of -$292.05 thousand (-3.36%) on September 30, 2024.
- Over the past year, INVO quarterly long term liabilities has dropped by -$964.15 thousand (-10.31%).
Performance
INVO Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
INVO Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +604.4% | -10.3% |
| 3 y3 years | +303.8% | +354.4% |
| 5 y5 years | +100.0% | +354.4% |
INVO Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -85.8% | -41.0% | -80.8% |
| 5 y | 5-year | at high | -85.8% | -41.0% | -80.8% |
| alltime | all time | at high | -100.0% | -41.0% | -100.0% |
INVO Bioscience Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $8.39 M(-3.4%) |
| Jun 2024 | - | $8.68 M(-7.2%) |
| Mar 2024 | - | $9.35 M(-20.6%) |
| Dec 2023 | $11.78 M(+604.4%) | $11.78 M(-17.2%) |
| Sep 2023 | - | $14.22 M(+266.9%) |
| Jun 2023 | - | $3.88 M(+140.3%) |
| Mar 2023 | - | $1.61 M(-3.5%) |
| Dec 2022 | $1.67 M(-12.1%) | $1.67 M(-3.4%) |
| Sep 2022 | - | $1.73 M(-3.3%) |
| Jun 2022 | - | $1.79 M(-3.1%) |
| Mar 2022 | - | $1.85 M(-3.0%) |
| Dec 2021 | $1.90 M(-34.8%) | $1.90 M(-47.9%) |
| Sep 2021 | - | $3.65 M(-5.3%) |
| Jun 2021 | - | $3.86 M(+41.1%) |
| Mar 2021 | - | $2.73 M(-6.3%) |
| Dec 2020 | $2.92 M(-27.2%) | $2.92 M(-21.4%) |
| Sep 2020 | - | $3.71 M(-13.4%) |
| Jun 2020 | - | $4.28 M(+23.5%) |
| Mar 2020 | - | $3.47 M(-13.4%) |
| Dec 2019 | $4.01 M(>+9900.0%) | $4.01 M(-3.2%) |
| Sep 2019 | - | $4.14 M(-3.2%) |
| Jun 2019 | - | $4.28 M(>+9900.0%) |
| Mar 2019 | - | $0.00(0.0%) |
| Dec 2018 | $0.00 | $0.00(0.0%) |
| Sep 2018 | - | $0.00(-100.0%) |
| Jun 2018 | - | $188.20 K(+42.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $131.70 K(0.0%) |
| Dec 2017 | $131.70 K(0.0%) | $131.70 K(0.0%) |
| Sep 2017 | - | $131.70 K(0.0%) |
| Jun 2017 | - | $131.70 K(0.0%) |
| Mar 2017 | - | $131.70 K(0.0%) |
| Dec 2016 | $131.70 K(>+9900.0%) | $131.70 K(0.0%) |
| Sep 2016 | - | $131.70 K(>+9900.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | - |
| Dec 2013 | $0.00(0.0%) | - |
| Dec 2012 | $0.00(0.0%) | - |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) |
| Jun 2011 | - | $0.00(-100.0%) |
| Mar 2011 | - | $40.00 K(>+9900.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2010 | - | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2009 | - | $0.00(-100.0%) |
| Jun 2009 | - | $96.50 K(0.0%) |
| Mar 2009 | - | $96.50 K(+65.0%) |
| Dec 2008 | $58.50 K(>+9900.0%) | $58.50 K |
| Dec 2006 | $0.00 | - |
FAQ
- What is INVO Bioscience annual total long term liabilities?
- What is the all time high annual total long term liabilities for INVO Bioscience?
- What is INVO Bioscience annual total long term liabilities year-on-year change?
- What is INVO Bioscience quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for INVO Bioscience?
- What is INVO Bioscience quarterly long term liabilities year-on-year change?
What is INVO Bioscience annual total long term liabilities?
The current annual total long term liabilities of INVO is $11.78 M
What is the all time high annual total long term liabilities for INVO Bioscience?
INVO Bioscience all-time high annual total long term liabilities is $11.78 M
What is INVO Bioscience annual total long term liabilities year-on-year change?
Over the past year, INVO annual total long term liabilities has changed by +$10.10 M (+604.35%)
What is INVO Bioscience quarterly total long term liabilities?
The current quarterly long term liabilities of INVO is $8.39 M
What is the all time high quarterly long term liabilities for INVO Bioscience?
INVO Bioscience all-time high quarterly total long term liabilities is $14.22 M
What is INVO Bioscience quarterly long term liabilities year-on-year change?
Over the past year, INVO quarterly total long term liabilities has changed by -$964.15 K (-10.31%)